About

Andrew Muddle, PhD, Co-founder and Ambassador at MedPharm, is a transdermal and topical drug delivery expert.

He co-founded MedPharm in August 1999. He has spent over 25 years in pharmaceutical drug delivery in roles of increasing seniority. He has focused on ensuring that MedPharm’s commercial proposals meet customers’ expectations and overseeing the consistent, strong growth of the company from its very beginnings. Prior to MedPharm, Dr Muddle was Technical Director (Pharmaceutical Development) at PowderJect Pharmaceuticals, where he was pivotal in its IPO in 1997.

Contributions

EARLY INSIGHT

AN ANGLED MICRONEEDLE PATCH FOR ENHANCED DRUG AND VACCINE DELIVERY

Nicky Bertollo, Ronan Byrne and Andrew Muddle introduce Pharma Latch – a user-centric angled microneedle patch technology. They discuss its key benefits, such as dramatically increased payload potential, precision, low cost and variable patch-wear times, and highlight how Pharma Latch has the potential to overcome many of the limitations of existing routes of administration for therapeutics and vaccines.